Levisign 500mg Tablet contains Levetiracetam 500mg, an antiepileptic medication primarily used to manage and prevent seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit abnormal neuronal firing and reduce seizure activity. This medication is indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients aged four years and above. Levisign is typically administered orally, with dosage individualized based on patient response and clinical condition. It is well-absorbed with rapid onset of action and minimal drug interactions, making it suitable for adjunctive therapy or monotherapy. Common adverse effects may include dizziness, somnolence, headache, and fatigue, though it is generally well tolerated. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Levisign should be used under strict medical supervision, with regular monitoring to assess efficacy and tolerability. Patients are advised not to discontinue therapy abruptly to avoid the risk of increased seizure frequency. This medication should be stored in a cool, dry place away from direct sunlight and out of reach of children.